Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea · Delayed Price · Currency is KRW 6,800.00
+350.00 (5.43%)
At close: Apr 3, 2026
Finemedix Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1,878 | -24.15 | 1,176 | 239.58 | -1,410 |
Depreciation & Amortization | 961.79 | 995.65 | 964.01 | 959.62 | 983.4 |
Loss (Gain) From Sale of Assets | -4.87 | 180 | - | -1,382 | -10.53 |
Loss (Gain) From Sale of Investments | - | - | - | - | 6.15 |
Loss (Gain) on Equity Investments | - | - | - | 240 | - |
Stock-Based Compensation | 77.88 | 106.38 | 17.73 | - | - |
Provision & Write-off of Bad Debts | 144.96 | 64.92 | 8.82 | 1.39 | -11.19 |
Other Operating Activities | -551.77 | 174.68 | 160.49 | 559.48 | 91.96 |
Change in Accounts Receivable | -175.8 | -317.04 | -472.59 | -840.73 | 709.22 |
Change in Inventory | -1,114 | -875.32 | -128.5 | -686.44 | -247.65 |
Change in Accounts Payable | -52.38 | -27.13 | -34.84 | 30.31 | -210.88 |
Change in Unearned Revenue | -0.17 | - | -10.12 | 0.14 | 10.15 |
Change in Other Net Operating Assets | -42.06 | -107.32 | -302.9 | -556.31 | 299.1 |
Operating Cash Flow | -2,634 | 170.68 | 1,378 | -1,435 | 210.19 |
Operating Cash Flow Growth | - | -87.61% | - | - | 2.25% |
Capital Expenditures | -852.1 | -595.45 | -336.13 | -691.8 | -1,086 |
Sale of Property, Plant & Equipment | 7.26 | - | - | 3,770 | 10.45 |
Cash Acquisitions | - | - | - | - | 0.88 |
Divestitures | - | - | - | 200 | - |
Sale (Purchase) of Intangibles | -1 | - | - | -2.76 | -141.92 |
Investment in Securities | -4,037 | 780.25 | 577.8 | -1,404 | -299.48 |
Other Investing Activities | -23.93 | 46.6 | 205.09 | 2.66 | -82.86 |
Investing Cash Flow | -4,907 | 124.91 | 546.76 | 1,774 | -1,599 |
Short-Term Debt Issued | - | - | 1,900 | - | - |
Long-Term Debt Issued | 1,177 | - | - | - | 1,000 |
Total Debt Issued | 1,177 | - | 1,900 | - | 1,000 |
Short-Term Debt Repaid | -400 | - | -1,000 | - | - |
Long-Term Debt Repaid | -480.57 | -542.68 | -2,115 | -1,739 | -1,693 |
Total Debt Repaid | -880.57 | -542.68 | -3,115 | -1,739 | -1,693 |
Net Debt Issued (Repaid) | 296.64 | -542.68 | -1,215 | -1,739 | -692.72 |
Issuance of Common Stock | - | 9,270 | - | - | - |
Other Financing Activities | -30.71 | -559.97 | - | -80 | 80 |
Financing Cash Flow | 265.93 | 8,167 | -1,215 | -1,819 | -612.72 |
Foreign Exchange Rate Adjustments | 0.88 | 65.05 | -6.11 | -42.32 | 25.71 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - |
Net Cash Flow | -7,274 | 8,528 | 703.97 | -1,522 | -1,976 |
Free Cash Flow | -3,486 | -424.77 | 1,042 | -2,127 | -875.99 |
Free Cash Flow Margin | -36.61% | -4.26% | 10.26% | -26.12% | -12.08% |
Free Cash Flow Per Share | -642.29 | -87.93 | 227.36 | -472.25 | -269.47 |
Cash Interest Paid | 87.69 | 126.41 | 102.39 | 60.04 | 183.99 |
Cash Income Tax Paid | 237.76 | 42.69 | 43.39 | -0.61 | 3.94 |
Levered Free Cash Flow | -2,930 | -938.72 | 406.62 | -2,159 | -1,161 |
Unlevered Free Cash Flow | -2,872 | -865.84 | 530.88 | -1,999 | -1,012 |
Change in Working Capital | -1,384 | -1,327 | -948.95 | -2,053 | 559.95 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.